Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in germany

Ulrich Stölzel, Erich Köstler, Christiane Koszka, Maricka Stöffler‐Meilicke, Detlef Schuppan, Rajan Somasundaram, Manfred O. Doss, Karl O. Habermehl, Ernst O. Riecken – 1 June 1995 – Previous studies from Spain, Italy, and France have demonstrated a high prevalence (71% to 91%) of antibodies against hepatitis C virus in patients with porphyria cutanea tarda (PCT). To determine the role of hepatitis C virus (HCV) in PCT in Germany, we have assessed the prevalence of antibodies against HCV and hepatitis B virus (HBV) in 106 patients (mean age, 60 ± 14 years) with the disease.

Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial

Ming‐Chih Hou, Han‐Chieh Lin, Benjamin Ing‐Tiau Kuo, Chen‐Hsiang Chen, Fa‐Yauh Lee, Shou‐Dong Lee – 1 June 1995 – To determine the efficacy of endoscopic variceal sclerotherapy (EVS) and ligation (EVL) in the management of esophageal variceal bleeding, 134 cirrhotic patients were randomized to receive either treatment. The clinical and endoscopic characteristics were similar in both groups. Active bleeding was controlled with ligation (20 of 20) as efficiently as with sclerotherapy (14 of 16).

Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes

Andreas K. Nussler, Mauricio Di Silvio, Zhi‐Ze Liu, David A. Geller, Paul Freeswick, Kenneth Dorko, Fabio Bartoli, Timothy R. Billiar – 1 June 1995 – Marked differences in induced nitric oxide (NO) synthesis occur between species. We have previously shown that both human and rat hepatocytes express an inducible NO synthase in response to cytokines and lipopolysaccharide. In this study, we compare the expression and regulation of cytokine‐induced NO synthase in hepatocytes isolated from three species, human, rat, and mouse.

Participation of small intraportal stem cells in the restitutive response of the liver to periportal necrosis induced by allyl alcohol

Leonid Yavorkovsky, Eva Lai, Zoran Ilic, Stewart Sell – 1 June 1995 – To determine the involvement of different hepatocyte populations in response to periportal injury, the restitutive response to allyl alcohol (AA) injury was examined.

DNA damage and donor livers: Disease unbidden?

Kathleen Schwarz – 1 June 1995 – Endogenous DNA adducts may contribute to the etiology of human genetic disease and cancer. One potential source of endogenous DNA adducts is lipid peroxidation, which generates mutagenic carbonyl compounds such as malondialdehyde. A sensitive mass spectrometric method permitted detection and quantitation of the major malondialdehyde‐DNA adduct, a pyrimidopurinone derived from deoxyguanosine. DNA from disease‐free human liver was found to contain 5400 adducts per cell, a frequency comparable to that of adducts formed by exogenous carcinogens.

Protective effect of hepatocyte growth factor on interferon‐gamma—induced cytotoxicity in mouse hepatocytes

Masahiko Morita, Yoshifumi Watanabe, Toshihiro Akaike – 1 June 1995 – We examined the interactive effect of several cytokines (interleukin‐1 beta [IL‐1β], tumor necrosis factor alpha [TNF‐α], interferon gamma [IFN‐γ], IL‐6, IFN‐α/B, and hepatocyte growth factor [HGF]) presumably involved in hepatitis, on primary cultured murine hepatocytes. Among these cytokines, only IFN‐γ induced LDH release from hepatocytes in both time‐ and dose‐dependent fashions. The cytotoxic effect was inhibited by antiserum—containing anti‐mouse IFN‐γ monoclonal antibodies (R4‐6A2).

Permissiveness of kupffer cells for simian immunodeficiency virus (SIV) and morphological changes in the liver of rhesus monkeys at different periods of SIV infection

Yury Persidsky, Anne‐Marie Steffan, Jean‐Louis Gendrault, Bruno Hurtrel, Stefan Berger, Cathy Royer, Hans‐Jochen Stutte, Elizabeth Muchmore, Anne‐Marie Aubertin, André Kirn – 1 May 1995 – The pathogenesis of liver injury, which remains unclear in the course of human immunodeficiency virus infection, can be investigated in simian immunodeficiency virus—infected macaques, which develop an immunodeficiency disease resembling human acquired immune deficiency syndrome (AIDS).

Subscribe to